Top Markets
#1 Black Phoenix Black Phoenix +829.12%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +32.51%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.20%
#4 Beam Beam +22.22%
#5 SAFEcoin SAFEcoin +20.72%
#6 YFSX YFSX +20.23%
#7 pipedog pipedog +20.01%
#8 Magma Finance Magma Finance +18.36%
#9 Bless Bless +16.87%
#10 THORChain THORChain +15.83%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Duality Biotherapeutics, Inc. Duality Biotherapeutics, Inc.

Duality Biotherapeutics, Inc.

9606
Rank in Stocks #6046
Operating as a clinical-stage enterprise, Duality Biotherapeutics, Inc.... Operating as a clinical-stage enterprise, Duality Biotherapeutics, Inc. concentrates on pioneering next-generation antibody-drug conjugate (ADC) therapies and proprietary duality immune toxin antibody conjugate (ITAC) solutions. The firm was founded by Zhu Zhong Yuan on July 3, 2019, and its main offices are situated in Shanghai, China.
Share Price
$25.01
Market Cap
$2.26B
Change (1 day)
-1.21%
Change (1 year)
-37.74%
Country
CN
Trade Duality Biotherapeutics, Inc. (9606)

Category

Healthcare
Earnings for Duality Biotherapeutics, Inc. (9606)
Earnings in 2026 TTM: 0
According to Duality Biotherapeutics, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Duality Biotherapeutics, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH